DOCETAXEL

DOCETAXEL was reported 68096 times

DOCETAXEL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LACRIMAL STRUCTURE INJURY 268 0.7109
1 MULTIFOCAL MICRONODULAR PNEUMOCYTE HYPERPLASIA 24 0.7059
2 HAIR DISORDER 5625 0.6820
3 BRONCHIAL POLYP 24 0.6486
4 MADAROSIS 6718 0.5782
5 HAIR COLOUR CHANGES 5874 0.4715
6 HAIR TEXTURE ABNORMAL 5993 0.4476
7 DESMOPLASTIC SMALL ROUND CELL TUMOUR 37 0.4253
8 BIOPSY LUNG ABNORMAL 38 0.3800
9 AMAUROSIS FUGAX 234 0.2173
10 NAIL TOXICITY 64 0.2133
11 DACRYOSTENOSIS ACQUIRED 247 0.1912
12 HER2 POSITIVE BREAST CANCER 62 0.1653
13 ALOPECIA AREATA 290 0.1651
14 HORMONE-REFRACTORY PROSTATE CANCER 196 0.1650
15 ALOPECIA TOTALIS 49 0.1489
16 DELUSION OF GRANDEUR 66 0.1470
17 RECALL PHENOMENON 120 0.1435
18 AORTITIS 92 0.1341
19 METASTASES TO SOFT TISSUE 32 0.1236
20 TOXIC ERYTHEMA OF CHEMOTHERAPY 31 0.1197
21 OESOPHAGEAL FISTULA 37 0.1164
22 METASTASES TO SKIN 113 0.1094
23 PSEUDOCIRRHOSIS 36 0.1084
24 NEUTROPENIC INFECTION 100 0.1045
25 PORTAL VENOUS GAS 37 0.1019
26 MUCOSAL INFECTION 23 0.0983
27 NAIL DYSTROPHY 55 0.0982
28 DEFORMITY 915 0.0978
29 RETINITIS PIGMENTOSA 25 0.0954
30 METASTASES TO THE MEDIASTINUM 39 0.0947
31 ONYCHOLYSIS 148 0.0946
32 NAIL BED INFLAMMATION 30 0.0940
33 PIK3CA-ACTIVATED MUTATION 31 0.0934
34 PSYCHOLOGICAL TRAUMA 787 0.0911
35 METASTASES TO PLEURA 92 0.0877
36 GASTROINTESTINAL ANASTOMOTIC LEAK 34 0.0872
37 ALOPECIA 16994 0.0864
38 RADIATION SKIN INJURY 99 0.0853
39 URETERITIS 23 0.0821
40 EJECTION FRACTION 47 0.0809
41 METASTASES TO LYMPH NODES 512 0.0758
42 BONE MARROW INFILTRATION 29 0.0749
43 PROSTATE CANCER METASTATIC 247 0.0739
44 SYSTEMIC SCLERODERMA 52 0.0714
45 NEUTROPENIC COLITIS 141 0.0681
46 MYELOSUPPRESSION 2438 0.0676
47 NEUTROPENIC SEPSIS 479 0.0670
48 PROSTATE CANCER RECURRENT 38 0.0617
49 BILIARY SEPSIS 27 0.0583
50 ACUTE INTERSTITIAL PNEUMONITIS 30 0.0575
51 METASTASES TO BONE 914 0.0556
52 BREAST CANCER RECURRENT 174 0.0550
53 TRIPLE NEGATIVE BREAST CANCER 37 0.0550
54 LYMPHANGIOSIS CARCINOMATOSA 57 0.0547
55 METASTASES TO ADRENALS 50 0.0542
56 INVASIVE DUCTAL BREAST CARCINOMA 147 0.0540
57 METASTASES TO BONE MARROW 27 0.0540
58 METASTASES TO LUNG 622 0.0538
59 GRANULOCYTE COUNT DECREASED 98 0.0528
60 COMPUTERISED TOMOGRAM THORAX ABNORMAL 36 0.0524
61 PERIPHERAL SENSORY NEUROPATHY 292 0.0499
62 LYMPHOCYTE COUNT ABNORMAL 56 0.0497
63 MUCOSAL INFLAMMATION 1303 0.0497
64 URINARY TRACT DISORDER 222 0.0492
65 PLEURAL DISORDER 30 0.0478
66 METASTASES TO ABDOMINAL CAVITY 23 0.0467
67 FEBRILE NEUTROPENIA 3101 0.0467
68 CAPILLARY LEAK SYNDROME 96 0.0464
69 SKIN TOXICITY 256 0.0453
70 INVASIVE LOBULAR BREAST CARCINOMA 23 0.0448
71 NASAL MUCOSAL DISORDER 26 0.0446
72 ENTEROCOLITIS INFECTIOUS 41 0.0444
73 LEFT VENTRICULAR DYSFUNCTION 296 0.0441
74 METASTASES TO CENTRAL NERVOUS SYSTEM 569 0.0441
75 RETROPERITONEAL LYMPHADENOPATHY 23 0.0436
76 VASOGENIC CEREBRAL OEDEMA 31 0.0431
77 CARDIOTOXICITY 383 0.0429
78 METASTASES TO LIVER 742 0.0422
79 METASTASES TO PERITONEUM 103 0.0407
80 HAEMATOTOXICITY 387 0.0407
81 ANHEDONIA 1051 0.0400
82 HYDROTHORAX 33 0.0398
83 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 927 0.0397
84 POLYNEUROPATHY 474 0.0395
85 SUBCLAVIAN VEIN THROMBOSIS 45 0.0395
86 METASTASES TO SPINE 131 0.0389
87 EJECTION FRACTION DECREASED 604 0.0388
88 METASTASES TO MENINGES 88 0.0387
89 BREAST CANCER METASTATIC 414 0.0385
90 GASTROINTESTINAL TOXICITY 183 0.0381
91 PARONYCHIA 167 0.0380
92 ACUTE PROMYELOCYTIC LEUKAEMIA 39 0.0379
93 NEOPLASM RECURRENCE 123 0.0362
94 DILATED CARDIOMYOPATHY 36 0.0356
95 CUTANEOUS SYMPTOM 24 0.0351
96 METASTASIS 249 0.0348
97 ANASTOMOTIC LEAK 24 0.0346
98 CARBOHYDRATE ANTIGEN 15-3 INCREASED 26 0.0342
99 IMPAIRED QUALITY OF LIFE 491 0.0341
100 HAEMORRHAGIC STROKE 261 0.0334
101 DIFFUSE ALOPECIA 62 0.0334
102 HEPATITIS B REACTIVATION 104 0.0327
103 GASTROINTESTINAL NECROSIS 95 0.0326
104 TONSILLAR DISORDER 36 0.0320
105 PROSTATIC SPECIFIC ANTIGEN INCREASED 436 0.0316
106 STREPTOCOCCAL SEPSIS 37 0.0312
107 ONYCHALGIA 31 0.0309
108 EMOTIONAL DISTRESS 3615 0.0298
109 FOLATE DEFICIENCY 34 0.0294
110 SYSTOLIC DYSFUNCTION 31 0.0294
111 HAIR GROWTH ABNORMAL 201 0.0290
112 NON-SMALL CELL LUNG CANCER 139 0.0290
113 NAIL DISORDER 253 0.0289
114 OSTEOSCLEROSIS 45 0.0286
115 MALIGNANT PLEURAL EFFUSION 48 0.0284
116 DERMATOMYOSITIS 70 0.0276
117 OESOPHAGEAL PERFORATION 23 0.0276
118 RADIATION PNEUMONITIS 59 0.0275
119 MALIGNANT NEOPLASM PROGRESSION 2800 0.0273
120 ADENOCARCINOMA 61 0.0272
121 MUCOSAL DISORDER 27 0.0272
122 BONE MARROW FAILURE 552 0.0271
123 BREAST NEOPLASM 28 0.0271
124 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 28 0.0270
125 VASCULAR DEVICE INFECTION 122 0.0269
126 BONE LESION 96 0.0266
127 TROPONIN I INCREASED 44 0.0264
128 PNEUMATOSIS INTESTINALIS 75 0.0263
129 TUMOUR PAIN 34 0.0258
130 SECOND PRIMARY MALIGNANCY 214 0.0257
131 TUMOUR NECROSIS 27 0.0255
132 GENERALISED OEDEMA 316 0.0255
133 NEUTROPHIL COUNT DECREASED 1039 0.0255
134 MUSCLE NECROSIS 23 0.0253
135 NEUTROPENIA 3418 0.0251
136 ADMINISTRATION SITE EXTRAVASATION 24 0.0240
137 PHARYNGEAL INFLAMMATION 29 0.0238
138 LEUKOPENIA 1179 0.0235
139 LYMPHOEDEMA 162 0.0234
140 PSEUDOMONAL SEPSIS 41 0.0234
141 PULMONARY TOXICITY 163 0.0230
142 MASTECTOMY 40 0.0229
143 DISEASE PROGRESSION 2702 0.0228
144 PNEUMONITIS 621 0.0228
145 ENTEROCOLITIS 131 0.0227
146 PALMAR ERYTHEMA 26 0.0225
147 DISCOMFORT 1359 0.0223
148 VULVOVAGINAL CANDIDIASIS 30 0.0222
149 DERMATITIS ACNEIFORM 135 0.0222
150 OCULAR DISCOMFORT 249 0.0222
151 STREPTOCOCCAL BACTERAEMIA 24 0.0221
152 INTESTINAL ISCHAEMIA 121 0.0220
153 RHINALGIA 60 0.0218
154 OSTEOLYSIS 44 0.0215
155 CARDIAC DYSFUNCTION 80 0.0215
156 MONOCYTE COUNT DECREASED 26 0.0213
157 SOFT TISSUE INFECTION 39 0.0213
158 FEBRILE INFECTION 25 0.0212
159 CYSTOID MACULAR OEDEMA 40 0.0212
160 LACRIMATION INCREASED 628 0.0208
161 MENTAL FATIGUE 31 0.0207
162 OSTEOCHONDROSIS 24 0.0207
163 SEROMA 26 0.0204
164 NEOPLASM PROGRESSION 711 0.0204
165 SARCOMA 23 0.0203
166 LUNG ADENOCARCINOMA 61 0.0203
167 HYPERSENSITIVITY PNEUMONITIS 23 0.0202
168 INJURY 1413 0.0201
169 PERIPHERAL MOTOR NEUROPATHY 28 0.0200
170 ERYSIPELAS 100 0.0199
171 ORGANISING PNEUMONIA 98 0.0198
172 EXCESSIVE EYE BLINKING 29 0.0196
173 AGRANULOCYTOSIS 364 0.0196
174 NAIL INFECTION 28 0.0195
175 INTERSTITIAL LUNG DISEASE 944 0.0195
176 METASTATIC NEOPLASM 84 0.0195
177 CYSTITIS NONINFECTIVE 26 0.0194
178 CYSTITIS HAEMORRHAGIC 78 0.0193
179 OSTEONECROSIS OF JAW 475 0.0192
180 GASTRIC PERFORATION 52 0.0191
181 THERAPY PARTIAL RESPONDER 296 0.0190
182 HYPOALBUMINAEMIA 147 0.0189
183 LYMPHADENOPATHY MEDIASTINAL 36 0.0188
184 PARAPARESIS 33 0.0185
185 VENTRICULAR HYPOKINESIA 59 0.0184
186 NAIL DISCOLOURATION 72 0.0183
187 NEUROPATHY PERIPHERAL 1725 0.0181
188 LARGE INTESTINE PERFORATION 125 0.0180
189 TUMOUR HAEMORRHAGE 51 0.0179
190 ALVEOLITIS 25 0.0177
191 ASCITES 519 0.0176
192 AXILLARY PAIN 26 0.0175
193 JUGULAR VEIN THROMBOSIS 31 0.0174
194 FEBRILE BONE MARROW APLASIA 74 0.0174
195 MYOSITIS 155 0.0173
196 CANCER PAIN 44 0.0172
197 GENE MUTATION 34 0.0172
198 ACQUIRED GENE MUTATION 22 0.0168
199 ONYCHOMADESIS 70 0.0167
200 HEPATIC LESION 72 0.0166
201 PNEUMOMEDIASTINUM 30 0.0166
202 PORTAL HYPERTENSION 51 0.0165
203 APLASIA 32 0.0163
204 NEUROTOXICITY 286 0.0163
205 PERFORMANCE STATUS DECREASED 76 0.0163
206 ACUTE MYELOID LEUKAEMIA 253 0.0162
207 GASTROINTESTINAL PERFORATION 67 0.0161
208 STOMATITIS 974 0.0160
209 GRANULOCYTOPENIA 91 0.0160
210 HYPOCALCAEMIA 299 0.0158
211 PSEUDOMEMBRANOUS COLITIS 35 0.0157
212 DYSAESTHESIA 48 0.0156
213 ODYNOPHAGIA 91 0.0152
214 CONGESTIVE CARDIOMYOPATHY 63 0.0151
215 HYPOPROTEINAEMIA 28 0.0147
216 MEGACOLON 23 0.0146
217 PLEURAL EFFUSION 891 0.0146
218 ABDOMINAL INFECTION 37 0.0145
219 SYSTEMIC INFECTION 24 0.0145
220 HAEMOLYTIC URAEMIC SYNDROME 33 0.0142
221 HYPOKALAEMIA 657 0.0142
222 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 33 0.0142
223 ACUTE LYMPHOCYTIC LEUKAEMIA 40 0.0141
224 HEAD DISCOMFORT 248 0.0140
225 TONGUE COATED 24 0.0139
226 ALTERED STATE OF CONSCIOUSNESS 301 0.0139
227 EMBOLISM 115 0.0138
228 NECROTISING FASCIITIS 48 0.0136
229 NASAL DISORDER 36 0.0135
230 EOSINOPHIL COUNT DECREASED 32 0.0134
231 ENTERITIS 86 0.0134
232 HYPOMAGNESAEMIA 186 0.0133
233 LUNG CONSOLIDATION 37 0.0132
234 HYDRONEPHROSIS 99 0.0132
235 NEUTROPHIL COUNT INCREASED 135 0.0132
236 HAEMATEMESIS 333 0.0131
237 OESOPHAGITIS 143 0.0131
238 HYPERTRANSAMINASAEMIA 91 0.0131
239 HYPOVOLAEMIC SHOCK 61 0.0127
240 THROMBOCYTOPENIA 1410 0.0126
241 EMBOLISM VENOUS 38 0.0125
242 COLITIS 473 0.0125
243 EXPOSED BONE IN JAW 27 0.0124
244 PAPILLOEDEMA 56 0.0124
245 SELF ESTEEM DECREASED 30 0.0124
246 STRESS CARDIOMYOPATHY 72 0.0124
247 HYPERPYREXIA 52 0.0123
248 PYELONEPHRITIS ACUTE 24 0.0122
249 PRESYNCOPE 297 0.0122
250 CARDIAC FAILURE CHRONIC 52 0.0122
251 ANXIETY 3462 0.0122
252 PNEUMOCYSTIS JIROVECII PNEUMONIA 122 0.0121
253 CLOSTRIDIAL INFECTION 41 0.0121
254 CARDIOMYOPATHY 179 0.0121
255 BLOOD CREATINE INCREASED 53 0.0120
256 OESOPHAGEAL STENOSIS 34 0.0119
257 ANAEMIA 2277 0.0119
258 SMALL INTESTINAL HAEMORRHAGE 24 0.0119
259 HEPATIC FUNCTION ABNORMAL 444 0.0119
260 LEUKOENCEPHALOPATHY 44 0.0118
261 SPINAL CORD COMPRESSION 46 0.0118
262 VULVOVAGINAL DRYNESS 38 0.0117
263 PULMONARY MASS 174 0.0117
264 WHITE BLOOD CELL COUNT DECREASED 1256 0.0116
265 DUODENAL ULCER 81 0.0115
266 LUNG INFILTRATION 101 0.0114
267 PNEUMOTHORAX 181 0.0114
268 ESCHERICHIA SEPSIS 33 0.0114
269 LEUKOCYTOSIS 206 0.0114
270 MYELODYSPLASTIC SYNDROME 164 0.0113
271 RECURRENT CANCER 46 0.0113
272 HAEMATURIA 385 0.0112
273 LICHEN PLANUS 26 0.0112
274 ORAL CANDIDIASIS 146 0.0111
275 TUMOUR LYSIS SYNDROME 97 0.0110
276 LUNG OPACITY 29 0.0110
277 ORTHOPNOEA 35 0.0110
278 BLEPHARITIS 44 0.0110
279 LUNG ABSCESS 23 0.0110
280 LARYNGEAL OEDEMA 67 0.0109
281 DISSEMINATED INTRAVASCULAR COAGULATION 153 0.0109
282 PHOTOPHOBIA 204 0.0108
283 ORAL INTAKE REDUCED 26 0.0107
284 MENOPAUSAL SYMPTOMS 25 0.0107
285 DERMATITIS 225 0.0107
286 DEVICE RELATED INFECTION 165 0.0107
287 VENOUS THROMBOSIS 42 0.0107
288 SEPTIC SHOCK 464 0.0107
289 CARDIAC FAILURE ACUTE 71 0.0106
290 ESCHERICHIA BACTERAEMIA 25 0.0106
291 NEUTROPHIL COUNT ABNORMAL 30 0.0106
292 BLOOD LACTATE DEHYDROGENASE INCREASED 168 0.0106
293 CARDIAC TAMPONADE 50 0.0105
294 SEPSIS 1161 0.0104
295 HAEMANGIOMA 24 0.0104
296 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 34 0.0103
297 ACUTE HEPATIC FAILURE 140 0.0102
298 NECROSIS 57 0.0102
299 DUODENAL ULCER HAEMORRHAGE 29 0.0101
300 ATYPICAL PNEUMONIA 30 0.0100
301 LYMPHOPENIA 141 0.0100
302 ABDOMINAL RIGIDITY 27 0.0099
303 SCLERODERMA 36 0.0099
304 INTESTINAL PERFORATION 111 0.0099
305 TYPE IV HYPERSENSITIVITY REACTION 27 0.0098
306 ACUTE RESPIRATORY DISTRESS SYNDROME 174 0.0098
307 COLITIS ISCHAEMIC 66 0.0098
308 PLEURITIC PAIN 27 0.0098
309 TRANSAMINASES INCREASED 216 0.0097
310 BLOOD ALKALINE PHOSPHATASE INCREASED 240 0.0097
311 ARTERIOSPASM CORONARY 38 0.0095
312 ELECTROLYTE IMBALANCE 110 0.0095
313 LYMPHOCYTE COUNT DECREASED 165 0.0093
314 NEPHROPATHY TOXIC 104 0.0093
315 CYTOPENIA 113 0.0092
316 HYPOVOLAEMIA 54 0.0092
317 HEPATOTOXICITY 204 0.0092
318 AFFECTIVE DISORDER 72 0.0091
319 DRUG RESISTANCE 235 0.0091
320 HICCUPS 75 0.0091
321 CACHEXIA 47 0.0091
322 HEPATIC CYST 31 0.0091
323 DIPLOPIA 237 0.0091
324 THROMBOTIC MICROANGIOPATHY 88 0.0090
325 LUNG CANCER METASTATIC 26 0.0090
326 AREFLEXIA 24 0.0090
327 CHEMOTHERAPY 34 0.0090
328 BUNDLE BRANCH BLOCK LEFT 38 0.0090
329 BLOOD CREATININE DECREASED 28 0.0089
330 MENOPAUSE 23 0.0089
331 PERICARDIAL EFFUSION 206 0.0089
332 GAMMA-GLUTAMYLTRANSFERASE INCREASED 197 0.0089
333 PATHOLOGICAL FRACTURE 45 0.0089
334 SUDDEN DEATH 93 0.0088
335 EXTRAVASATION 36 0.0088
336 BONE PAIN 513 0.0087
337 SKIN EROSION 28 0.0087
338 CARDIO-RESPIRATORY ARREST 358 0.0086
339 PANCYTOPENIA 477 0.0085
340 OESOPHAGEAL CANDIDIASIS 34 0.0085
341 CHEST X-RAY ABNORMAL 26 0.0085
342 RED CELL DISTRIBUTION WIDTH INCREASED 35 0.0084
343 VASCULITIS 98 0.0084
344 HYPONATRAEMIA 472 0.0084
345 ASPARTATE AMINOTRANSFERASE INCREASED 443 0.0083
346 WOUND DEHISCENCE 28 0.0083
347 DYSPNOEA AT REST 24 0.0083
348 HYPERURICAEMIA 34 0.0083
349 DIARRHOEA 5334 0.0083
350 HYPOPHOSPHATAEMIA 61 0.0082
351 THROMBOTIC THROMBOCYTOPENIC PURPURA 29 0.0082
352 LOCALISED OEDEMA 38 0.0082
353 ACUTE CORONARY SYNDROME 68 0.0082
354 MOUTH ULCERATION 172 0.0082
355 IMMUNE-MEDIATED ENTEROCOLITIS 30 0.0081
356 ONYCHOCLASIS 56 0.0081
357 LUNG INFECTION 126 0.0081
358 CIRCULATORY COLLAPSE 138 0.0081
359 FUNCTIONAL GASTROINTESTINAL DISORDER 28 0.0081
360 ALANINE AMINOTRANSFERASE INCREASED 496 0.0081
361 ILEUS PARALYTIC 36 0.0081
362 PORTAL VEIN THROMBOSIS 26 0.0080
363 ASTHENOPIA 44 0.0080
364 HAEMOPTYSIS 222 0.0080
365 UROSEPSIS 73 0.0079
366 EYE INJURY 24 0.0079
367 FAILURE TO THRIVE 41 0.0079
368 KERATITIS 24 0.0079
369 BLINDNESS 321 0.0079
370 DECREASED APPETITE 1809 0.0078
371 HYPOXIA 273 0.0077
372 C-REACTIVE PROTEIN INCREASED 280 0.0077
373 SINUS TACHYCARDIA 109 0.0077
374 TYPE I HYPERSENSITIVITY 27 0.0077
375 RESPIRATORY FAILURE 559 0.0077
376 CLOSTRIDIUM DIFFICILE COLITIS 81 0.0076
377 POST-TRAUMATIC STRESS DISORDER 51 0.0076
378 MITRAL VALVE INCOMPETENCE 86 0.0076
379 BREAST MASS 51 0.0076
380 DEHYDRATION 1008 0.0075
381 SUSPECTED OFF LABEL USE 34 0.0075
382 DISEASE RECURRENCE 357 0.0075
383 STAPHYLOCOCCAL SEPSIS 37 0.0075
384 SHOCK HAEMORRHAGIC 61 0.0075
385 ATELECTASIS 72 0.0074
386 GENERAL PHYSICAL HEALTH DETERIORATION 862 0.0074
387 LYMPHADENOPATHY 262 0.0074
388 EMBOLIC STROKE 26 0.0074
389 PERIPHERAL ISCHAEMIA 30 0.0073
390 HYDROCEPHALUS 40 0.0073
391 BACTERAEMIA 87 0.0073
392 PYREXIA 2520 0.0073
393 PULMONARY TUBERCULOSIS 31 0.0072
394 SPINAL PAIN 85 0.0072
395 CELLULITIS 364 0.0072
396 TOXIC SKIN ERUPTION 71 0.0070
397 LUNG NEOPLASM 30 0.0070
398 ILEUS 87 0.0070
399 VARICOSE VEIN 36 0.0070
400 CORONARY ARTERY STENOSIS 35 0.0070
401 TACHYCARDIA 618 0.0069
402 PERITONITIS 144 0.0069
403 PULMONARY ALVEOLAR HAEMORRHAGE 39 0.0069
404 TRICUSPID VALVE INCOMPETENCE 55 0.0069
405 DERMATITIS BULLOUS 50 0.0069
406 INFUSION RELATED REACTION 456 0.0069
407 PHLEBITIS 35 0.0068
408 TACHYPNOEA 92 0.0068
409 HYPERBILIRUBINAEMIA 70 0.0068
410 SARCOIDOSIS 32 0.0067
411 ORAL PAIN 150 0.0067
412 HEPATIC FAILURE 200 0.0066
413 PROTEINURIA 126 0.0066
414 BREAST PAIN 70 0.0066
415 ERYTHEMA MULTIFORME 61 0.0065
416 MYOCARDIAL ISCHAEMIA 74 0.0065
417 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 62 0.0065
418 SKIN REACTION 91 0.0065
419 CANDIDA INFECTION 109 0.0064
420 APPENDICITIS 60 0.0064
421 RASH VESICULAR 31 0.0064
422 PYELONEPHRITIS 55 0.0063
423 SKIN INFECTION 71 0.0063
424 EPISTAXIS 472 0.0063
425 WHITE BLOOD CELL COUNT ABNORMAL 40 0.0063
426 BLOOD BILIRUBIN INCREASED 169 0.0062
427 PNEUMONIA ASPIRATION 156 0.0062
428 ABDOMINAL TENDERNESS 31 0.0062
429 PULMONARY HAEMORRHAGE 48 0.0061
430 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 63 0.0061
431 CHOLECYSTITIS 73 0.0061
432 HYPERGLYCAEMIA 223 0.0061
433 LOSS OF LIBIDO 55 0.0061
434 GINGIVAL SWELLING 27 0.0061
435 TINNITUS 280 0.0061
436 SMALL INTESTINAL OBSTRUCTION 75 0.0061
437 OESOPHAGEAL PAIN 24 0.0061
438 SUPRAVENTRICULAR TACHYCARDIA 58 0.0061
439 ACUTE PULMONARY OEDEMA 34 0.0061
440 SUBCUTANEOUS ABSCESS 29 0.0060
441 PULMONARY EMBOLISM 574 0.0060
442 GASTROENTERITIS 88 0.0060
443 VOMITING 2824 0.0060
444 GASTRITIS 158 0.0060
445 CARDIAC FAILURE 480 0.0060
446 CHOLANGITIS 37 0.0060
447 GASTRIC ULCER HAEMORRHAGE 33 0.0059
448 HYPOPHAGIA 152 0.0059
449 BLOOD ALBUMIN DECREASED 47 0.0059
450 SCHIZOPHRENIA 72 0.0059
451 ISCHAEMIA 27 0.0059
452 COMA 279 0.0059
453 HYPERCALCAEMIA 72 0.0058
454 CEREBRAL ISCHAEMIA 30 0.0058
455 PLATELET COUNT DECREASED 619 0.0058
456 ASPIRATION 63 0.0057
457 FACE OEDEMA 97 0.0057
458 PSEUDOMONAS INFECTION 49 0.0057
459 ANURIA 49 0.0057
460 INFLAMMATORY MARKER INCREASED 28 0.0056
461 NEUTROPHILIA 32 0.0056
462 CHILLS 659 0.0056
463 MULTI-ORGAN FAILURE 97 0.0056
464 SKIN HYPERPIGMENTATION 48 0.0056
465 OSTEONECROSIS 183 0.0056
466 MULTIPLE ORGAN DYSFUNCTION SYNDROME 157 0.0055
467 BRAIN OEDEMA 70 0.0055
468 STAPHYLOCOCCAL BACTERAEMIA 24 0.0055
469 LOWER RESPIRATORY TRACT INFECTION 251 0.0055
470 BLOOD CALCIUM DECREASED 62 0.0055
471 ASTHENIA 2072 0.0055
472 CONJUNCTIVITIS 102 0.0055
473 ACIDOSIS 42 0.0055
474 HEPATIC CYTOLYSIS 70 0.0055
475 BONE DISORDER 100 0.0055
476 FLUSHING 556 0.0055
477 OEDEMA 293 0.0054
478 VEIN DISORDER 27 0.0054
479 PLEURISY 32 0.0054
480 INTRACRANIAL PRESSURE INCREASED 30 0.0054
481 LIVER INJURY 132 0.0054
482 ABDOMINAL PAIN 1238 0.0053
483 OEDEMA PERIPHERAL 648 0.0053
484 SARS-COV-2 TEST POSITIVE 70 0.0053
485 SYNCOPE 528 0.0053
486 EYELID OEDEMA 61 0.0052
487 EYE PAIN 296 0.0052
488 ANAL ABSCESS 28 0.0052
489 ANGIOPATHY 29 0.0052
490 GUILLAIN-BARRE SYNDROME 25 0.0052
491 INFUSION SITE EXTRAVASATION 32 0.0051
492 HAEMOGLOBIN ABNORMAL 33 0.0051
493 HYPERTRIGLYCERIDAEMIA 30 0.0051
494 DYSPNOEA EXERTIONAL 193 0.0051
495 HYPERTHERMIA 39 0.0051
496 MOUTH HAEMORRHAGE 37 0.0050
497 SKIN NECROSIS 26 0.0050
498 PROSTATE CANCER 403 0.0050
499 PULMONARY FIBROSIS 96 0.0050
500 VISUAL FIELD DEFECT 36 0.0050
501 DYSPHAGIA 468 0.0049
502 NAUSEA 3877 0.0049
503 RETINAL DETACHMENT 45 0.0049
504 HAEMATOCRIT DECREASED 96 0.0048
505 MYALGIA 821 0.0048
506 OXYGEN SATURATION DECREASED 271 0.0048
507 GINGIVITIS 26 0.0048
508 MYOCARDITIS 55 0.0048
509 DEEP VEIN THROMBOSIS 311 0.0048
510 DYSGEUSIA 355 0.0048
511 HYPERCHLORHYDRIA 28 0.0048
512 KLEBSIELLA INFECTION 24 0.0047
513 CHEST DISCOMFORT 486 0.0047
514 ADRENAL INSUFFICIENCY 57 0.0047
515 HAEMOLYTIC ANAEMIA 42 0.0047
516 COMPRESSION FRACTURE 25 0.0047
517 TOOTH EXTRACTION 58 0.0047
518 MALNUTRITION 52 0.0046
519 HEPATITIS B 28 0.0046
520 BRONCHOPULMONARY ASPERGILLOSIS 36 0.0046
521 MACULAR OEDEMA 26 0.0046
522 BREAST CANCER 432 0.0046
523 UNRESPONSIVE TO STIMULI 119 0.0046
524 CEREBRAL INFARCTION 112 0.0046
525 CLOSTRIDIUM DIFFICILE INFECTION 100 0.0046
526 RESPIRATORY TRACT INFECTION 119 0.0046
527 ACUTE KIDNEY INJURY 695 0.0045
528 CONCOMITANT DISEASE AGGRAVATED 28 0.0045
529 HALLUCINATION, AUDITORY 72 0.0045
530 RASH PUSTULAR 33 0.0045
531 MUSCULOSKELETAL CHEST PAIN 70 0.0045
532 SHOCK 104 0.0045
533 UTERINE LEIOMYOMA 33 0.0045
534 RESPIRATORY RATE INCREASED 40 0.0045
535 PHOTOSENSITIVITY REACTION 74 0.0045
536 ARTERIOSCLEROSIS 42 0.0045
537 HAEMOGLOBIN DECREASED 458 0.0045
538 BLOOD CREATININE INCREASED 291 0.0045
539 TRISMUS 23 0.0044
540 DRUG-INDUCED LIVER INJURY 139 0.0044
541 TOXIC EPIDERMAL NECROLYSIS 67 0.0044
542 MELAENA 97 0.0044
543 TONSILLITIS 23 0.0044
544 BLOOD MAGNESIUM DECREASED 38 0.0044
545 ENCEPHALOPATHY 108 0.0044
546 GINGIVAL PAIN 35 0.0044
547 CARDIOGENIC SHOCK 63 0.0044
548 ABSCESS 70 0.0044
549 HYPERAESTHESIA 36 0.0044
550 MAJOR DEPRESSION 32 0.0044
551 NEPHROTIC SYNDROME 30 0.0044
552 ORAL DISORDER 32 0.0044
553 RASH MACULO-PAPULAR 97 0.0044
554 WHITE BLOOD CELL COUNT INCREASED 167 0.0043
555 SKIN MASS 29 0.0043
556 PNEUMONIA 1406 0.0043
557 PAIN IN JAW 123 0.0043
558 URINARY RETENTION 143 0.0043
559 DYSPNOEA 2410 0.0043
560 APHTHOUS ULCER 33 0.0043
561 PNEUMONIA BACTERIAL 39 0.0042
562 HOT FLUSH 320 0.0042
563 ACUTE MYOCARDIAL INFARCTION 125 0.0042
564 FATIGUE 3289 0.0042
565 ATAXIA 50 0.0042
566 TROPONIN INCREASED 32 0.0042
567 CYANOSIS 66 0.0042
568 SKIN FISSURES 82 0.0042
569 IMMUNOSUPPRESSION 37 0.0042
570 DRUG TOXICITY 57 0.0042
571 BLOOD UREA INCREASED 70 0.0042
572 SENSORY DISTURBANCE 67 0.0042
573 BLOOD DISORDER 33 0.0041
574 ANOREXIA 53 0.0041
575 DEPRESSION 935 0.0041
576 WOUND INFECTION 45 0.0041
577 PEMPHIGOID 31 0.0041
578 FACIAL PARALYSIS 35 0.0041
579 INFECTION 594 0.0041
580 FOLLICULITIS 43 0.0041
581 STEVENS-JOHNSON SYNDROME 91 0.0041
582 NEOPLASM 47 0.0041
583 FOREIGN BODY SENSATION IN EYES 26 0.0041
584 ERYTHEMA 833 0.0040
585 PIGMENTATION DISORDER 25 0.0040
586 RENAL CYST 32 0.0040
587 POSTOPERATIVE WOUND INFECTION 27 0.0040
588 DYSURIA 147 0.0040
589 SWELLING OF EYELID 25 0.0040
590 ORTHOSTATIC HYPOTENSION 69 0.0040
591 CHOLESTASIS 76 0.0040
592 ACUTE RESPIRATORY FAILURE 76 0.0039
593 HAEMODYNAMIC INSTABILITY 30 0.0039
594 CONSTIPATION 854 0.0039
595 DRUG INTOLERANCE 377 0.0039
596 DERMATITIS ALLERGIC 49 0.0039
597 URINE OUTPUT DECREASED 34 0.0039
598 TASTE DISORDER 78 0.0038
599 RENAL FAILURE ACUTE 163 0.0038
600 PULMONARY OEDEMA 172 0.0038
601 TOXICITY TO VARIOUS AGENTS 646 0.0038
602 PANCREATITIS ACUTE 86 0.0038
603 FISTULA 43 0.0038
604 LIVER FUNCTION TEST INCREASED 82 0.0038
605 PAIN 2340 0.0038
606 HYPERKALAEMIA 133 0.0038
607 BACK PAIN 881 0.0038
608 PHARYNGITIS 47 0.0038
609 LUNG DISORDER 185 0.0038
610 RESPIRATORY DISTRESS 104 0.0038
611 HEPATOMEGALY 37 0.0038
612 ATRIAL FLUTTER 30 0.0038
613 OSTEOMYELITIS 68 0.0038
614 ATRIAL FIBRILLATION 364 0.0037
615 BODY TEMPERATURE INCREASED 76 0.0037
616 LETHARGY 214 0.0037
617 CENTRAL NERVOUS SYSTEM LESION 51 0.0037
618 SKIN DISORDER 123 0.0037
619 GENERAL PHYSICAL CONDITION ABNORMAL 25 0.0037
620 HYPERTENSIVE CRISIS 41 0.0037
621 CEREBRAL DISORDER 27 0.0036
622 DUODENAL ULCER PERFORATION 27 0.0036
623 DRUG ERUPTION 64 0.0036
624 BLOOD SODIUM DECREASED 68 0.0036
625 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 27 0.0036
626 COUGH 1005 0.0036
627 HYPOTENSION 718 0.0036
628 GASTROINTESTINAL DISORDER 320 0.0036
629 ANAPHYLACTIC SHOCK 92 0.0036
630 GASTRIC HAEMORRHAGE 41 0.0036
631 THROAT TIGHTNESS 96 0.0035
632 SKIN LESION 97 0.0035
633 DRY EYE 176 0.0035
634 FLANK PAIN 33 0.0035
635 SKIN ULCER 91 0.0035
636 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 29 0.0035
637 SPINAL COMPRESSION FRACTURE 29 0.0035
638 TOOTH INFECTION 46 0.0035
639 SENSORY LOSS 28 0.0035
640 GASTRIC ULCER 66 0.0035
641 RECTAL HAEMORRHAGE 149 0.0035
642 DIVERTICULITIS 96 0.0035
643 INFUSION SITE ERYTHEMA 29 0.0034
644 ANAPHYLACTIC REACTION 190 0.0034
645 DECUBITUS ULCER 28 0.0034
646 NASAL DISCOMFORT 27 0.0034
647 STAPHYLOCOCCAL INFECTION 112 0.0034
648 UPPER GASTROINTESTINAL HAEMORRHAGE 57 0.0034
649 VITAMIN D DEFICIENCY 33 0.0034
650 HAEMORRHOIDS 66 0.0034
651 RENAL IMPAIRMENT 284 0.0034
652 FACIAL PAIN 30 0.0034
653 PETECHIAE 35 0.0034
654 RHINITIS 27 0.0033
655 TOOTH ABSCESS 34 0.0033
656 POST PROCEDURAL INFECTION 27 0.0033
657 DIARRHOEA HAEMORRHAGIC 31 0.0033
658 DYSPEPSIA 320 0.0032
659 NEURALGIA 79 0.0032
660 FEELING HOT 199 0.0032
661 RED BLOOD CELL COUNT DECREASED 92 0.0032
662 TREATMENT FAILURE 266 0.0032
663 BLOOD POTASSIUM DECREASED 96 0.0032
664 ANGINA PECTORIS 91 0.0032
665 HYPOTHYROIDISM 101 0.0032
666 HYPERSENSITIVITY 587 0.0032
667 LIVER DISORDER 140 0.0032
668 URINARY TRACT INFECTION 534 0.0031
669 MYOPATHY 27 0.0031
670 RENAL PAIN 33 0.0031
671 GASTROINTESTINAL PAIN 34 0.0031
672 CARDIOMEGALY 38 0.0031
673 JAUNDICE 83 0.0031
674 VENTRICULAR EXTRASYSTOLES 32 0.0031
675 CYSTITIS 98 0.0031
676 OFF LABEL USE 2673 0.0030
677 SKIN EXFOLIATION 257 0.0030
678 PARAESTHESIA 475 0.0030
679 ULCER 48 0.0030
680 HEPATIC STEATOSIS 56 0.0030
681 METABOLIC ACIDOSIS 96 0.0030
682 OROPHARYNGEAL DISCOMFORT 27 0.0030
683 PRODUCT USE IN UNAPPROVED INDICATION 739 0.0030
684 PERICARDITIS 50 0.0030
685 VENTRICULAR FIBRILLATION 33 0.0030
686 AGEUSIA 74 0.0030
687 AMENORRHOEA 52 0.0030
688 PULMONARY CONGESTION 39 0.0030
689 GASTROINTESTINAL INFLAMMATION 23 0.0029
690 COGNITIVE DISORDER 137 0.0029
691 TOOTHACHE 53 0.0029
692 THERAPEUTIC RESPONSE DECREASED 176 0.0029
693 OVARIAN CYST 29 0.0029
694 EXTRAPYRAMIDAL DISORDER 72 0.0029
695 NOCTURIA 35 0.0029
696 PSYCHOTIC DISORDER 85 0.0029
697 DRUG INTERACTION 456 0.0029
698 ARRHYTHMIA 135 0.0028
699 PRODUCTIVE COUGH 136 0.0028
700 CARDIAC ARREST 232 0.0028
701 SCAB 32 0.0028
702 ESCHERICHIA INFECTION 23 0.0028
703 MASS 39 0.0028
704 TENDERNESS 29 0.0028
705 RASH 1211 0.0028
706 MUSCULOSKELETAL PAIN 144 0.0027
707 DIABETIC KETOACIDOSIS 66 0.0027
708 STATUS EPILEPTICUS 31 0.0027
709 CHEST PAIN 508 0.0027
710 BRONCHOSPASM 39 0.0027
711 UPPER RESPIRATORY TRACT INFECTION 126 0.0027
712 SKIN PLAQUE 23 0.0027
713 EPILEPSY 83 0.0027
714 NO THERAPEUTIC RESPONSE 33 0.0027
715 DEVICE OCCLUSION 38 0.0027
716 HEPATITIS 69 0.0027
717 ISCHAEMIC STROKE 48 0.0027
718 MENTAL STATUS CHANGES 73 0.0026
719 OROPHARYNGEAL PAIN 243 0.0026
720 GROIN PAIN 23 0.0026
721 BRAIN NEOPLASM 24 0.0026
722 HYPOAESTHESIA 390 0.0026
723 CARDIAC FAILURE CONGESTIVE 208 0.0026
724 GASTROINTESTINAL HAEMORRHAGE 216 0.0026
725 HYPERTENSION 544 0.0026
726 MICTURITION URGENCY 29 0.0025
727 PLATELET COUNT INCREASED 33 0.0025
728 WEIGHT DECREASED 706 0.0025
729 BLISTER 142 0.0025
730 BLOOD PRESSURE DECREASED 168 0.0025
731 BLOOD PRESSURE INCREASED 386 0.0025
732 CEREBRAL HAEMORRHAGE 90 0.0025
733 EYE DISCHARGE 26 0.0025
734 SEIZURE 288 0.0025
735 MUSCULAR WEAKNESS 283 0.0025
736 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 177 0.0025
737 ARTHRALGIA 1025 0.0025
738 ABDOMINAL PAIN UPPER 506 0.0025
739 RESPIRATORY DISORDER 73 0.0024
740 RED BLOOD CELL SEDIMENTATION RATE INCREASED 27 0.0024
741 VISION BLURRED 333 0.0024
742 BRAIN FOG 38 0.0024
743 HEPATIC ENZYME INCREASED 164 0.0024
744 RASH ERYTHEMATOUS 115 0.0024
745 THERAPY NON-RESPONDER 108 0.0024
746 COAGULOPATHY 40 0.0024
747 RENAL FAILURE 318 0.0024
748 SPLENOMEGALY 28 0.0024
749 INFLAMMATION 123 0.0024
750 NODULE 31 0.0024
751 CARDIOVASCULAR DISORDER 60 0.0024
752 RENAL TUBULAR NECROSIS 23 0.0023
753 ABDOMINAL PAIN LOWER 59 0.0023
754 JOINT STIFFNESS 61 0.0023
755 ILL-DEFINED DISORDER 141 0.0023
756 QUALITY OF LIFE DECREASED 31 0.0023
757 THROMBOSIS 185 0.0023
758 HEPATOCELLULAR INJURY 32 0.0023
759 IMPAIRED HEALING 74 0.0023
760 DEAFNESS 58 0.0022
761 MUSCLE ATROPHY 28 0.0022
762 MALAISE 967 0.0022
763 HYPOAESTHESIA ORAL 33 0.0022
764 BRADYCARDIA 116 0.0022
765 CORONARY ARTERY DISEASE 66 0.0022
766 NERVOUS SYSTEM DISORDER 68 0.0022
767 OSTEOPENIA 33 0.0022
768 FRACTURE 41 0.0022
769 DEATH 1862 0.0022
770 DELIRIUM 75 0.0022
771 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 37 0.0022
772 INTESTINAL OBSTRUCTION 81 0.0021
773 BACTERIAL INFECTION 40 0.0021
774 HAEMORRHAGE INTRACRANIAL 32 0.0021
775 PULMONARY ARTERIAL HYPERTENSION 31 0.0021
776 HEMIPARESIS 36 0.0021
777 RASH PRURITIC 115 0.0021
778 CHOLELITHIASIS 69 0.0021
779 ECZEMA 110 0.0021
780 GLOSSODYNIA 47 0.0021
781 PALPITATIONS 245 0.0021
782 PRURITUS 803 0.0021
783 HEPATIC CIRRHOSIS 39 0.0021
784 HYPOKINESIA 30 0.0021
785 INSOMNIA 550 0.0021
786 VENTRICULAR TACHYCARDIA 34 0.0021
787 VISUAL ACUITY REDUCED 68 0.0020
788 PERIPHERAL COLDNESS 28 0.0020
789 REBOUND EFFECT 23 0.0020
790 LOWER LIMB FRACTURE 39 0.0020
791 LIVER FUNCTION TEST ABNORMAL 59 0.0020
792 DEPRESSED LEVEL OF CONSCIOUSNESS 80 0.0020
793 DIZZINESS 992 0.0020
794 UNINTENTIONAL MEDICAL DEVICE REMOVAL 23 0.0020
795 DYSPHONIA 116 0.0020
796 IMPAIRED GASTRIC EMPTYING 27 0.0020
797 PULMONARY HYPERTENSION 41 0.0020
798 RASH PAPULAR 44 0.0020
799 TENDONITIS 30 0.0019
800 PAIN IN EXTREMITY 567 0.0019
801 HYPOGLYCAEMIA 93 0.0019
802 VERTIGO 116 0.0019
803 MENTAL DISORDER 82 0.0019
804 INTENTIONAL PRODUCT USE ISSUE 165 0.0019
805 GENERALISED TONIC-CLONIC SEIZURE 31 0.0019
806 PELVIC PAIN 34 0.0019
807 FLUID RETENTION 95 0.0019
808 APHONIA 26 0.0019
809 HAEMORRHAGE 194 0.0019
810 GASTROOESOPHAGEAL REFLUX DISEASE 149 0.0018
811 CONDITION AGGRAVATED 559 0.0018
812 ELECTROCARDIOGRAM QT PROLONGED 66 0.0018
813 EATING DISORDER 39 0.0018
814 OBESITY 29 0.0018
815 TUBULOINTERSTITIAL NEPHRITIS 34 0.0018
816 HAEMATOMA 47 0.0018
817 CATARACT 107 0.0018
818 BLOOD POTASSIUM INCREASED 29 0.0018
819 FEEDING DISORDER 36 0.0018
820 PALLOR 48 0.0018
821 DEPRESSED MOOD 93 0.0018
822 GINGIVAL BLEEDING 24 0.0018
823 PHARYNGEAL OEDEMA 27 0.0018
824 APHASIA 53 0.0018
825 ABDOMINAL DISTENSION 182 0.0017
826 PARAESTHESIA ORAL 25 0.0017
827 DYSARTHRIA 65 0.0017
828 SKIN DISCOLOURATION 79 0.0017
829 PERIPHERAL SWELLING 264 0.0017
830 HERPES ZOSTER 98 0.0017
831 ADVERSE EVENT 157 0.0017
832 CYTOMEGALOVIRUS INFECTION 28 0.0017
833 OSTEOPOROSIS 69 0.0017
834 SOMNOLENCE 337 0.0017
835 RESTLESSNESS 61 0.0017
836 HYPERTHYROIDISM 24 0.0017
837 INTERNATIONAL NORMALISED RATIO INCREASED 47 0.0016
838 COLD SWEAT 29 0.0016
839 RESPIRATORY ARREST 45 0.0016
840 POLLAKIURIA 68 0.0016
841 DRUG EFFECT INCOMPLETE 59 0.0016
842 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 84 0.0016
843 HEADACHE 1007 0.0016
844 LUNG NEOPLASM MALIGNANT 66 0.0016
845 HYPERHIDROSIS 204 0.0016
846 BRONCHITIS 117 0.0016
847 PREMATURE DELIVERY 25 0.0016
848 MUSCULOSKELETAL DISCOMFORT 27 0.0016
849 INFLUENZA LIKE ILLNESS 129 0.0016
850 DEVICE ADHESION ISSUE 24 0.0016
851 GASTROENTERITIS VIRAL 28 0.0015
852 FALL 514 0.0015
853 DRY MOUTH 125 0.0015
854 LOCALISED INFECTION 37 0.0015
855 SWELLING 142 0.0015
856 SWELLING FACE 98 0.0015
857 EMOTIONAL DISORDER 46 0.0015
858 HAEMATOCHEZIA 82 0.0015
859 PAIN OF SKIN 40 0.0015
860 RHINORRHOEA 96 0.0015
861 URINARY INCONTINENCE 44 0.0015
862 LOSS OF CONSCIOUSNESS 188 0.0015
863 SCAR 25 0.0015
864 LIMB DISCOMFORT 45 0.0015
865 TRANSIENT ISCHAEMIC ATTACK 49 0.0015
866 THROAT IRRITATION 65 0.0014
867 SCIATICA 23 0.0014
868 HYPOACUSIS 62 0.0014
869 DISORIENTATION 57 0.0014
870 EOSINOPHILIA 25 0.0014
871 HALLUCINATION, VISUAL 30 0.0014
872 RETCHING 30 0.0014
873 PRESCRIBED UNDERDOSE 28 0.0014
874 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 77 0.0014
875 TOOTH LOSS 29 0.0014
876 SPINAL FRACTURE 28 0.0014
877 HEART RATE INCREASED 138 0.0014
878 EAR PAIN 27 0.0014
879 SLEEP DISORDER 97 0.0014
880 DYSSTASIA 40 0.0014
881 RHABDOMYOLYSIS 57 0.0014
882 FEMUR FRACTURE 42 0.0014
883 CONFUSIONAL STATE 219 0.0014
884 DRUG INEFFECTIVE 1752 0.0013
885 PREMATURE BABY 40 0.0013
886 LACTIC ACIDOSIS 43 0.0013
887 HEART RATE IRREGULAR 30 0.0013
888 GAIT DISTURBANCE 254 0.0013
889 FUNGAL INFECTION 44 0.0013
890 NEOPLASM MALIGNANT 87 0.0013
891 BURNING SENSATION 90 0.0013
892 DRY SKIN 169 0.0013
893 VISUAL IMPAIRMENT 156 0.0013
894 BLOOD PRESSURE ABNORMAL 25 0.0013
895 SPEECH DISORDER 65 0.0012
896 GASTRIC CANCER 31 0.0012
897 MUSCULOSKELETAL DISORDER 23 0.0012
898 NIGHT SWEATS 38 0.0012
899 COVID-19 206 0.0012
900 BLOOD PRESSURE FLUCTUATION 28 0.0012
901 CARDIAC DISORDER 108 0.0012
902 PRODUCT PRESCRIBING ISSUE 25 0.0011
903 GAIT INABILITY 38 0.0011
904 URTICARIA 185 0.0011
905 DIABETES MELLITUS 84 0.0011
906 MOOD SWINGS 35 0.0011
907 RENAL DISORDER 51 0.0011
908 ERECTILE DYSFUNCTION 28 0.0011
909 MUSCLE TWITCHING 25 0.0011
910 WHEEZING 64 0.0011
911 FEELING COLD 30 0.0011
912 PANIC ATTACK 39 0.0011
913 MUSCLE SPASMS 193 0.0011
914 PRODUCT USE ISSUE 196 0.0010
915 BLOOD CREATINE PHOSPHOKINASE INCREASED 30 0.0010
916 TOOTH DISORDER 23 0.0010
917 CHROMATURIA 23 0.0010
918 DEMENTIA 28 0.0010
919 DISTURBANCE IN ATTENTION 54 0.0010
920 CHRONIC KIDNEY DISEASE 76 0.0010
921 VAGINAL HAEMORRHAGE 43 0.0010
922 PANCREATITIS 52 0.0010
923 MEMORY IMPAIRMENT 135 0.0010
924 EYE PRURITUS 33 0.0010
925 NASOPHARYNGITIS 180 0.0010
926 BREAST CANCER FEMALE 26 0.0010
927 ABDOMINAL DISCOMFORT 160 0.0010
928 EYE DISORDER 31 0.0009
929 EYE IRRITATION 54 0.0009
930 MOVEMENT DISORDER 30 0.0009
931 UNDERDOSE 67 0.0009
932 MYOCARDIAL INFARCTION 160 0.0009
933 RASH MACULAR 32 0.0009
934 FOETAL EXPOSURE DURING PREGNANCY 74 0.0009
935 OCULAR HYPERAEMIA 43 0.0009
936 CEREBROVASCULAR ACCIDENT 153 0.0009
937 TYPE 2 DIABETES MELLITUS 30 0.0009
938 INTENTIONAL PRODUCT MISUSE 78 0.0009
939 HEART RATE DECREASED 31 0.0009
940 NECK PAIN 49 0.0009
941 VIRAL INFECTION 29 0.0009
942 AMNESIA 55 0.0008
943 TREMOR 140 0.0008
944 EXPOSURE DURING PREGNANCY 52 0.0008
945 OSTEOARTHRITIS 35 0.0008
946 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 23 0.0008
947 GYNAECOMASTIA 24 0.0008
948 ADVERSE DRUG REACTION 69 0.0008
949 BALANCE DISORDER 66 0.0008
950 HEAD INJURY 24 0.0008
951 OVERDOSE 161 0.0007
952 ANGIOEDEMA 33 0.0007
953 JOINT SWELLING 90 0.0007
954 MATERNAL EXPOSURE DURING PREGNANCY 65 0.0007
955 CONVULSION 41 0.0007
956 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 34 0.0007
957 FLATULENCE 40 0.0007
958 ARTHROPATHY 38 0.0007
959 MOBILITY DECREASED 48 0.0007
960 MUSCULOSKELETAL STIFFNESS 55 0.0006
961 AGITATION 45 0.0006
962 INFLUENZA 68 0.0006
963 SINUSITIS 61 0.0006
964 CONTUSION 56 0.0006
965 SURGERY 34 0.0006
966 UNEVALUABLE EVENT 43 0.0006
967 ARTHRITIS 43 0.0005
968 HOSPITALISATION 83 0.0005
969 ASTHMA 61 0.0005
970 DEVICE LEAKAGE 23 0.0005
971 TREATMENT NONCOMPLIANCE 29 0.0005
972 WEIGHT INCREASED 117 0.0005
973 SUICIDAL IDEATION 47 0.0005
974 FEELING ABNORMAL 111 0.0005
975 BLOOD GLUCOSE INCREASED 86 0.0005
976 HALLUCINATION 32 0.0004
977 INCORRECT DOSE ADMINISTERED 95 0.0004
978 PSORIASIS 51 0.0004
979 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 67 0.0004
980 DEVICE MALFUNCTION 26 0.0004
981 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 26 0.0004
982 MIGRAINE 34 0.0004
983 ILLNESS 36 0.0003
984 ACNE 24 0.0003
985 NO ADVERSE EVENT 52 0.0003
986 PRODUCT QUALITY ISSUE 33 0.0002
987 ACCIDENTAL EXPOSURE TO PRODUCT 22 0.0002
988 INJECTION SITE ERYTHEMA 26 0.0002
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 39 0.0002
990 DRUG DOSE OMISSION 26 0.0002
991 INJECTION SITE PAIN 31 0.0001
992 PRODUCT DOSE OMISSION ISSUE 28 0.0001